New Jobless Claims Sub-2 Million 1st Time in Months
Anonymousdogmadogmassage.com
(Reuters) - Japans Kaneka Corp has entered into a deal to manufacture Inovio Pharmaceuticals Incs COVID-19 vaccine candidate, the U.S.-based vaccine maker said on Thursday. It did not disclose the terms of the agreement with Kaneka Eurogentec, a unit of the Japanese chemical company. Inovio has also signed manufacturing deals with medical device maker Thermo Fisher Scientific among others, to increase supply of the vaccine, which entered a mid-stage study last month. The Phase 3 of the mid-to-late stage study is under a partial hold by the U.S. Food and Drug Administration as it seeks more information, including details on a delivery device used to inject genetic material into cells. (Reporting by Amruta Khandekar; Editing by Shinjini Ganguli) View comments
Breaking Free from Alcohol: A Journey to Sobriety and Beyond
A personal reflection on overcoming alcohol addiction and the transformative effects of sobriety.